A retrospective review of comprehensive quality assurance databases of screening tests and cervical biopsy results from the Regional Laboratory of the Kaiser Permanente Northern California (KPNC ...

Traditional treatment of CIN 2 and CIN 3 is excisional therapy or ablation of the cervical transformation zone. The disease recurs in 5% to 26% of women, even with negative surgical margins.

Long-term risks of invasive cancer and recurrence of severe cervical intraepithelial neoplasia (CIN) are higher among women previously treated for CIN, compared with those with no ...

Smartphones are used in cervical screening for visual inspection after acetic acid or Lugol's iodine (VIA/VILI) application to capture and share images to improve the sensitivity and interobserver ...

Human papillomavirus (HPV) is the etiologic agent for cervical cancer. In Mexico, a women dies every 2 h, and since 1990 the statistics have shown that the numbers of deaths are increasing. We ...

Data suggest that the presence of the lowest level of change, cervical intraepithelial neoplasia (CIN) 1, does not lead to a significantly increased risk for development of the highest level of ...

The treatment aims to remove or destroy the abnormal cervical cells. CIN 1 doesn't normally need treatment as the cell changes often return to normal over time. CIN 2 may be monitored or treated, ...

The aim of this paper was to evaluate the factors that predict regression of untreated CIN 2 and 3. A total of 93 patients with colposcopic persistent CIN 2 and 3 lesions after biopsy were ...

Among women ages 20 to 24 who were screened for cervical cancer from 2008 to 2022, rates of cervical intraepithelial neoplasia (CIN) grades 2-3 and adenocarcinoma in situ (AIS), defined as CIN2 ...

The test detected E7 proteins in 80% of women with Stage 1 cervical intraepithelial neoplasia (CIN), a precursor to cervical cancer. It also found the proteins in 71% of women with Stage 2 CIN and ...